Health Care: Drugs

Merck & Co Inc (MRK: NYSE)

$61.13 n/a | n/a%
12/02/16 - 04:03 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 39.50B 42.24B 44.03B 47.27B
Cost of Sales 8.56B 10.08B 9.97B 9.47B
Gross Operating Profit 30.94B 32.16B 34.07B 37.80B
Selling, General, and Administrative Expenses 10.31B 11.61B 11.91B 12.78B
Research & Development 6.70B 7.18B 7.50B 8.17B
Operating Income before D & A (EBITDA) 13.92B 13.37B 14.65B 16.86B
Depreciation & Amortization 6.38B 6.69B 6.99B 6.98B
Interest Income 289.00M 266.00M 264.00M 232.00M
Other Income - Net -1.35B 11.82B -278.00M -634.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 6.07B 18.02B 6.35B 9.45B
Interest Expense 672.00M 732.00M 801.00M 714.00M
Pre-Tax Income 5.40B 17.28B 5.54B 8.74B
Income Taxes 942.00M 5.35B 1.03B 2.44B
Minority Interest 17.00M 14.00M 113.00M 131.00M
Net Income From Continuing Operations 4.46B 11.93B 4.52B 6.30B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.46B 11.93B 4.52B 6.30B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.44B 11.92B 4.40B 6.17B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.08B 12.95B 6.23B 6.96B
Preferred Dividends
Net Income Available To Common 4.46B 11.93B 4.52B 6.30B
Basic EPS from Continuing Ops. 1.58 4.12 1.49 2.03
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.58 4.12 1.49 2.03
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.58 4.12 1.49 2.03
Basic Normalized Net Income/Share 1.80 4.47 2.05 2.24
EPS fr Continuing Ops. 1.56 4.07 1.47 2.00
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.56 4.07 1.47 2.00
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.56 4.07 1.47 2.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.78 4.42 2.03 2.21
Dividends Paid per Share 1.81 1.77 1.73 1.69

Portfolios with MRK

Latest MRK Headlines from TheStreet

More Financial News for MRK

Press Releases for MRK

See All Press Releases

Partner Headlines for MRK

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter